微芯生物: 第三届监事会第十一次会议决议公告

Group 1 - The company held its 11th meeting of the 3rd Supervisory Board on August 25, 2025, with all 3 supervisors present, ensuring compliance with legal and regulatory requirements [1][2] - The Supervisory Board approved the 2025 Half-Year Report, confirming that the report's preparation and review processes adhered to relevant laws and internal regulations, and accurately reflected the company's financial status and operational results [1][2] - The Supervisory Board also approved the Special Report on the Storage and Actual Use of Raised Funds for the first half of 2025, confirming that the funds were stored in dedicated accounts and used appropriately without any violations [2]